BioWorld

Feb. 14, 2007

Omeros Raises $63M In Series E To Fund Broad Product Pipeline

Omeros Corp. set out to raise $20 million in its Series E financing round, but ended up bringing in more than $63 million by the time it was all over. (BioWorld Today) Read More

PDUFA Should Move Forward Unencumbered, BIO Advises

Pharmacopeia Gets $15M Up Front In Organon Deal

HGS Starts Phase III Trial With LymphoStat-B In Lupus

Cyclacel Raises $36M Through Direct Offering At Market Price

Locus Round Raises $30.2M To Push Cancer Drug, More

Other News To Note

Clinic Roundup

Today's news in brief

BioWorld

BioWorld briefs for July 16, 2026.

AI-generated illustration of a neuron with tau protein aggregation

AAIC 2026: Age of amyloid is being joined by time of tau

BioWorld

The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...

Celia trial: data strong, analysts skeptical

BioWorld

Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...

News in brief

BioWorld Asia

BioWorld Asia briefs for July 14, 2026

Voyager’s gene therapy reduces tau levels in AD models

BioWorld Science

At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...